Benjamin M Terry, MD | |
235 N Pearl St, Brockton, MA 02301-1794 | |
(508) 427-3000 | |
Not Available |
Full Name | Benjamin M Terry |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 16 Years |
Location | 235 N Pearl St, Brockton, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124288246 | NPI | - | NPPES |
110088628A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 245517 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Good Samaritan Medical Center | Brockton, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Steward Emergency Physicians Inc | 0244401404 | 148 |
News Archive
Thirty-five countries now face serious food shortages, including two dozen in Africa, according to a report released by the United Nations Food and Agricultural Organization (FAO).
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Qbrelis (Lisinopril) Oral Solution, the first and only FDA-approved Lisinopril oral solution.
Senate Democratic leaders are tracking the support of a government-run public option in health care reform legislation.
› Verified 9 days ago
Entity Name | Steward Emergency Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780971275 PECOS PAC ID: 0244401404 Enrollment ID: O20110919000768 |
News Archive
Thirty-five countries now face serious food shortages, including two dozen in Africa, according to a report released by the United Nations Food and Agricultural Organization (FAO).
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Qbrelis (Lisinopril) Oral Solution, the first and only FDA-approved Lisinopril oral solution.
Senate Democratic leaders are tracking the support of a government-run public option in health care reform legislation.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Benjamin M Terry, MD 29 Catherine Ave, Franklin, MA 02038-2787 Ph: () - | Benjamin M Terry, MD 235 N Pearl St, Brockton, MA 02301-1794 Ph: (508) 427-3000 |
News Archive
Thirty-five countries now face serious food shortages, including two dozen in Africa, according to a report released by the United Nations Food and Agricultural Organization (FAO).
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Qbrelis (Lisinopril) Oral Solution, the first and only FDA-approved Lisinopril oral solution.
Senate Democratic leaders are tracking the support of a government-run public option in health care reform legislation.
› Verified 9 days ago
Luis E. Ortiz, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 680 Centre St, Brockton, MA 02302 Phone: 508-941-7000 | |
Dr. Stephen J Simon, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Centre St, Brockton, MA 02302 Phone: 508-941-7000 | |
Grant Wei, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Centre St, Dept. Of Emergency Medicine, Brockton, MA 02302 Phone: 508-941-7400 | |
Jacob Kallenberg, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 235 N Pearl St, Brockton, MA 02301 Phone: 508-427-3075 | |
Daniel Werzanski, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Centre St, Brockton, MA 02302 Phone: 508-941-7000 | |
Laura A Griffin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 680 Centre Street, Brockton Hospital, Brockton, MA 02302 Phone: 508-941-7000 | |
Dr. Richard S. Herman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 235 North Pearl Street, Brockton, MA 02301 Phone: 508-427-3034 |